Search - tctmd.com

Displaying 801 - 820 of 3911

Sort: Relevancy | Date

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Presentation TVT 2023

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Presenter: Samir Kapadia

June 09, 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

News Daily News

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

June 08, 2023

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Presentation TVT 2023

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Presenter: Veronica Andre

June 08, 2023

Prevention and Management of Conduction Disturbances (With Case Examples)

Presentation TVT 2023

Prevention and Management of Conduction Disturbances (With Case Examples)

Presenter: Shmuel Chen

June 07, 2023

Prevention and Management of PVL: When to Intervene (With Case Examples)

Presentation TVT 2023

Prevention and Management of PVL: When to Intervene (With Case Examples)

Presenter: Amar Krishnaswamy

June 07, 2023

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

May 30, 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

May 25, 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

May 25, 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

May 24, 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 12, 2023

Continuous Mechanical Aspiration: Myocardial Perfusion and the Prevention of No Reflow

Presentation Fellows 2023

Continuous Mechanical Aspiration: Myocardial Perfusion and the Prevention of No Reflow

Presenter: Sahil Parikh

May 11, 2023

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

News Daily News

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

May 09, 2023

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

May 05, 2023

Troponin Trajectories Differ Over the Years for Men, Women

News Daily News

Troponin Trajectories Differ Over the Years for Men, Women

May 04, 2023

Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials

News Daily News

Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials

May 04, 2023

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.